Literature DB >> 313242

Effect of operation and radiotherapy on antibody-dependent cellular cytotoxicity.

J A McCredie, H R MacDonald, S B Wood.   

Abstract

A subpopulation of human lymphocytes bearing receptors for the Fe portion of IgG causes lysis of nucleated target cells in the presence of antibody. The reaction is known as antibody-dependent cellular cytotoxicity (ADCC) and the effector cells have been called killer (K) cells. We have measured K cell activity quantitatively in the peripheral blood of cancer patients using 51Cr labeled murine mastocytoma target cells and hyperimmune rabbit antimastocytoma antibody. ADCC was the same in males and females, was not affected by eating, smoking or the presence of infections, but was decreased in those over 65 years, during pregnancy, and in those with cachexia, or severe sepsis associated with nonmalignant diseases. It was normal in those with cancers being treated for cure and in those with benign diseases, but was decreased in those with advanced cancers. Operation did not produce a significant change in those who were not immunodepressed; in those who were immunodepressed before operation it caused a significant decrease maximal by the fifth day with recovery by the 15th day. Radiotherapy caused a decrease in K cell activity, maximal at 4 weeks, that persisted for 12 weeks with recovery after that time in those who did not have residual tumor. The values did not return to normal in those who had persistent tumor or distant metastases.

Entities:  

Mesh:

Year:  1979        PMID: 313242     DOI: 10.1002/1097-0142(197907)44:1<99::aid-cncr2820440118>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

Authors:  N Saijo; E Shimizu; N Irimajiri; A Ozaki; K Kimura; T Takizawa; H Niitani
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

2.  The nature of enhanced natural killer lymphocyte cytotoxicity during anesthesia and surgery in patients with benign disease and cancer.

Authors:  C D Griffith; R C Rees; A Platts; A Jermy; J Peel; K Rogers
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

3.  Antibody-dependent cellular cytotoxicity in cancer patients: lack of prognostic value.

Authors:  J A McCredie; H R MacDonald
Journal:  Br J Cancer       Date:  1980-06       Impact factor: 7.640

4.  Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.

Authors:  N Saijo; E Shimizu; M Shibuya; N Irimajiri; T Takizawa; K Eguchi; T Shinkai; K Tominaga; Z Shimabukuro; T Taniguchi; A Hoshi
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

5.  m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer.

Authors:  A M Pullyblank; P J Guillou; J R Monson
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.